Literature DB >> 30586570

Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.

W C Hochberger1, Y B Joshi2, W Zhang2, M L Thomas3, D L Braff2, N R Swerdlow2, G A Light4.   

Abstract

Abnormalities in early auditory information processing (EAIP) contribute to higher-order deficits in cognition and psychosocial functioning in schizophrenia. A passive auditory oddball paradigm is commonly used to evoke event-related potential (ERP) measures of EAIP reflecting auditory sensory registration and deviance detection, including mismatch negativity (MMN) and P3a responses. MMN and P3a have been extensively studied in healthy subjects and neuropsychiatric patient populations and are increasingly used as translational biomarkers in the development of novel therapeutics. Despite widespread use, relatively few studies have examined the constituent oscillatory elements and the extent to which sensory registration and deviance detection represent distinct or intercorrelated processes. This study aimed to determine the factor structure and clinical correlates of these oscillatory measures in schizophrenia patients (n = 706) and healthy comparison subjects (n = 615) who underwent clinical, cognitive, and functional characterization and EEG testing via their participation in the Consortium of Genomics in Schizophrenia (COGS-2) study. Results revealed significant deficits in theta-band (4-7 Hz) evoked power and phase locking in patients. Exploratory factor analyses of both ERP and oscillatory measures revealed two dissociable factors reflecting sensory registration and deviance detection. While each factor shared a significant correlation with social cognition, the deviance detection factor had a unique relationship to multiple cognitive and clinical domains. Results support the continued advancement of functionally relevant oscillatory measures underlying EAIP in the development of precognitive therapeutics. Published by Elsevier B.V.

Entities:  

Keywords:  COGS-2; Early auditory information processing; Mismatch negativity; Schizophrenia

Mesh:

Year:  2018        PMID: 30586570      PMCID: PMC7261144          DOI: 10.1016/j.ijpsycho.2018.12.014

Source DB:  PubMed          Journal:  Int J Psychophysiol        ISSN: 0167-8760            Impact factor:   2.997


  43 in total

Review 1.  Auditory processing that leads to conscious perception: a unique window to central auditory processing opened by the mismatch negativity and related responses.

Authors:  Risto Näätänen; Teija Kujala; István Winkler
Journal:  Psychophysiology       Date:  2010-09-29       Impact factor: 4.016

Review 2.  Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.

Authors:  Daniel C Javitt
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

3.  Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia.

Authors:  Claudia Lainscsek; Aaron L Sampson; Robert Kim; Michael L Thomas; Karen Man; Xenia Lainscsek; Neal R Swerdlow; David L Braff; Terrence J Sejnowski; Gregory A Light
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

4.  Mismatch negativity is a stronger indicator of functional outcomes than neurocognition or theory of mind in patients with schizophrenia.

Authors:  Seung-Hwan Lee; Kyongae Sung; Kyong-Sang Lee; Eunok Moon; Chang-Gyu Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-22       Impact factor: 5.067

5.  Low-frequency EEG oscillations associated with information processing in schizophrenia.

Authors:  Alan T Bates; Kent A Kiehl; Kristin R Laurens; Peter F Liddle
Journal:  Schizophr Res       Date:  2009-10-22       Impact factor: 4.939

6.  Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.

Authors:  William C Hochberger; Yash B Joshi; Michael L Thomas; Wendy Zhang; Andrew W Bismark; Emily B H Treichler; Melissa Tarasenko; John Nungaray; Joyce Sprock; Lauren Cardoso; Neal Swerdlow; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2018-10-30       Impact factor: 7.853

7.  Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia.

Authors:  Louise Dulude; Alain Labelle; Verner J Knott
Journal:  J Clin Psychopharmacol       Date:  2010-10       Impact factor: 3.153

8.  High dose D-serine in the treatment of schizophrenia.

Authors:  Joshua T Kantrowitz; Anil K Malhotra; Barbara Cornblatt; Gail Silipo; Andrea Balla; Raymond F Suckow; Cyril D'Souza; John Saksa; Scott W Woods; Daniel C Javitt
Journal:  Schizophr Res       Date:  2010-06-11       Impact factor: 4.939

9.  Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Authors:  Gregory A Light; Neal R Swerdlow; Michael L Thomas; Monica E Calkins; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Marlena Pela; Allen D Radant; Larry J Seidman; Richard F Sharp; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; David L Braff; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2014-10-23       Impact factor: 4.939

10.  Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia.

Authors:  Gregory A Light; Neal R Swerdlow; Anthony J Rissling; Allen Radant; Catherine A Sugar; Joyce Sprock; Marlena Pela; Mark A Geyer; David L Braff
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

View more
  3 in total

1.  Theta Phase Synchrony Is Sensitive to Corollary Discharge Abnormalities in Early Illness Schizophrenia but Not in the Psychosis Risk Syndrome.

Authors:  Brian J Roach; Judith M Ford; Rachel L Loewy; Barbara K Stuart; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

2.  Sources of the frontocentral mismatch negativity and P3a responses in schizophrenia patients and healthy comparison subjects.

Authors:  Daisuke Koshiyama; Makoto Miyakoshi; Yash B Joshi; Masaki Nakanishi; Kumiko Tanaka-Koshiyama; Joyce Sprock; Gregory A Light
Journal:  Int J Psychophysiol       Date:  2021-01-13       Impact factor: 2.997

Review 3.  A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology.

Authors:  Daniel C Javitt; Steven J Siegel; Kevin M Spencer; Daniel H Mathalon; L Elliot Hong; Antigona Martinez; Cindy L Ehlers; Atheir I Abbas; Tobias Teichert; Peter Lakatos; Thilo Womelsdorf
Journal:  Neuropsychopharmacology       Date:  2020-05-06       Impact factor: 8.294

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.